PortfoliosLab logoPortfoliosLab logo
MAG7.L vs. MRN3.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

MAG7.L vs. MRN3.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Leverage Shares 5x Long Magnificent 7 ETP Securities (MAG7.L) and Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MAG7.L vs. MRN3.L - Yearly Performance Comparison


2026 (YTD)20252024
MAG7.L
Leverage Shares 5x Long Magnificent 7 ETP Securities
-53.67%-28.43%150.95%
MRN3.L
Leverage Shares 3x Long Moderna (MRNA) ETP Securities
185.34%-93.67%-98.56%

Returns By Period

In the year-to-date period, MAG7.L achieves a -53.67% return, which is significantly lower than MRN3.L's 185.34% return.


MAG7.L

1D
18.44%
1M
-25.61%
YTD
-53.67%
6M
-53.35%
1Y
21.91%
3Y*
5Y*
10Y*

MRN3.L

1D
5.13%
1M
-28.06%
YTD
185.34%
6M
153.22%
1Y
23.95%
3Y*
-92.58%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MAG7.L vs. MRN3.L - Expense Ratio Comparison

Both MAG7.L and MRN3.L have an expense ratio of 0.75%.


Return for Risk

MAG7.L vs. MRN3.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MAG7.L
MAG7.L Risk / Return Rank: 2424
Overall Rank
MAG7.L Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
MAG7.L Sortino Ratio Rank: 3838
Sortino Ratio Rank
MAG7.L Omega Ratio Rank: 3232
Omega Ratio Rank
MAG7.L Calmar Ratio Rank: 1717
Calmar Ratio Rank
MAG7.L Martin Ratio Rank: 1717
Martin Ratio Rank

MRN3.L
MRN3.L Risk / Return Rank: 3434
Overall Rank
MRN3.L Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
MRN3.L Sortino Ratio Rank: 7070
Sortino Ratio Rank
MRN3.L Omega Ratio Rank: 5454
Omega Ratio Rank
MRN3.L Calmar Ratio Rank: 1919
Calmar Ratio Rank
MRN3.L Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MAG7.L vs. MRN3.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 5x Long Magnificent 7 ETP Securities (MAG7.L) and Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MAG7.LMRN3.LDifference

Sharpe ratio

Return per unit of total volatility

0.18

0.11

+0.07

Sortino ratio

Return per unit of downside risk

1.14

1.85

-0.70

Omega ratio

Gain probability vs. loss probability

1.14

1.21

-0.07

Calmar ratio

Return relative to maximum drawdown

0.25

0.34

-0.08

Martin ratio

Return relative to average drawdown

0.69

0.55

+0.13

MAG7.L vs. MRN3.L - Sharpe Ratio Comparison

The current MAG7.L Sharpe Ratio is 0.18, which is higher than the MRN3.L Sharpe Ratio of 0.11. The chart below compares the historical Sharpe Ratios of MAG7.L and MRN3.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MAG7.LMRN3.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.18

0.11

+0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

-0.43

+0.36

Correlation

The correlation between MAG7.L and MRN3.L is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

MAG7.L vs. MRN3.L - Dividend Comparison

Neither MAG7.L nor MRN3.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MAG7.L vs. MRN3.L - Drawdown Comparison

The maximum MAG7.L drawdown since its inception was -91.14%, smaller than the maximum MRN3.L drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for MAG7.L and MRN3.L.


Loading graphics...

Drawdown Indicators


MAG7.LMRN3.LDifference

Max Drawdown

Largest peak-to-trough decline

-91.14%

-100.00%

+8.86%

Max Drawdown (1Y)

Largest decline over 1 year

-71.56%

-81.28%

+9.72%

Current Drawdown

Current decline from peak

-74.60%

-100.00%

+25.40%

Average Drawdown

Average peak-to-trough decline

-46.88%

-97.52%

+50.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.35%

49.36%

-23.01%

Volatility

MAG7.L vs. MRN3.L - Volatility Comparison

The current volatility for Leverage Shares 5x Long Magnificent 7 ETP Securities (MAG7.L) is 37.26%, while Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) has a volatility of 67.32%. This indicates that MAG7.L experiences smaller price fluctuations and is considered to be less risky than MRN3.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MAG7.LMRN3.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

37.26%

67.32%

-30.06%

Volatility (6M)

Calculated over the trailing 6-month period

70.93%

163.13%

-92.20%

Volatility (1Y)

Calculated over the trailing 1-year period

120.58%

213.24%

-92.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

125.39%

223.41%

-98.02%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

125.39%

223.41%

-98.02%